Factors influencing warfarin dose requirements in African––Americans

By Momary Kathryn M   Shapiro Nancy L   Viana Marlos AG   Nutescu Edith A   Helgason Cathy M   Cavallari Larisa H  

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1535-1544

Future Medicine

Access to resources Recommend Favorite

Adherence and variability in warfarin dose requirements: assessment in a prospective cohort

By Jorgensen Andrea L   Hughes Dyfrig A   Hanson Anita   van Eker Diane   Toh Cheng Hock   Pirmohamed Munir   Williamson Paula R  

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 151-163

Future Medicine

Access to resources Recommend Favorite

Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients

By Nakai Kenji   Tsuboi Jyunichi   Okabayashi Hitoshi   Fukuhiro Yoshiaki   Oka Takanori   Habano Wataru   Fukushima Noriko   Nakai Keiko   Obara Wataru   Fujioka Tomoaki   Suwabe Akira   Gurwitz David  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 713-719

Future Medicine

Access to resources Recommend Favorite

Strategies for the management of GERD vary between different specialists in the Asia Pacific region

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 465, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic–Americans and African–Americans

By Bress Adam   Patel Shitalben R   Perera Minoli A   Campbell Richard T   Kittles Rick A   Cavallari Larisa H  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1925-1935

Future Medicine

Access to resources Recommend Favorite